Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Gritstone Bio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Gritstone Bio Inc market cap is $100.00.
What is the 52-week high for Gritstone Bio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Gritstone Bio Inc 52 week high is $1.05 as of September 28, 2025.
What is the 52-week low for Gritstone Bio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gritstone Bio Inc 52 week low is $0.00 as of September 28, 2025.
What is the PE ratio of Gritstone Bio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Gritstone Bio Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Gritstone Bio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Gritstone Bio Inc P/B ratio is 0.0000.
What is the 50-day moving average of Gritstone Bio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Gritstone Bio Inc 50-day moving average is $0.00.
